- Home
- BIIB vs MDB Comparison
BIIB vs MDB Comparison
Compare BIIB & MDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIIB | MDB |
|---|---|---|
| Founded | 1978 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.3B | 30.0B |
| IPO Year | 1996 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BIIB | MDB |
|---|---|---|
| Price | $202.96 | $305.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 34 |
| Target Price | $206.83 | ★ $368.67 |
| AVG Volume (30 Days) | 1.3M | ★ 1.5M |
| Earning Date | 04-29-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 49.13 |
| EPS | ★ 2.15 | 0.05 |
| Revenue | ★ $9,890,600,000.00 | N/A |
| Revenue This Year | N/A | $18.68 |
| Revenue Next Year | N/A | $17.10 |
| P/E Ratio | ★ $93.60 | $6,471.60 |
| Revenue Growth | ★ 2.22 | N/A |
| 52 Week Low | $124.56 | $198.47 |
| 52 Week High | $219.72 | $444.72 |
Technical Indicators
Market Signals| Indicator | BIIB | MDB |
|---|---|---|
| Relative Strength Index (RSI) | 50.53 | 40.44 |
| Support Level | $186.30 | $304.07 |
| Resistance Level | $219.72 | $350.47 |
| Average True Range (ATR) | 8.83 | 20.05 |
| MACD | -0.81 | -4.79 |
| Stochastic Oscillator | 51.24 | 3.37 |
Price Performance
Historical ComparisonAbout BIIB Biogen Inc.
Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).
About MDB MongoDB Inc.
Founded in 2007, MongoDB is a vendor of a document-oriented database that accelerates development processes of new applications. Enterprise customers can choose between the fully managed offering, MongoDB Atlas, or the self-managed version, MongoDB Enterprise Advanced. MongoDB is a popular tool among developers, and its free Community Server has recorded over 500 million downloads since 2009.